Cyclacel Pharmaceuticals

$6.82
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.40 (+6.15%) As of 4:41 PM UTC today

Why Robinhood?

You can buy or sell CYCC and other stocks, options, and ETFs commission-free!

About CYCC

Cyclacel Pharmaceuticals, Inc. Common Stock, also called Cyclacel Pharmaceuticals, is a clinical stage biopharmaceutical company.

CEO
Spiro Rombotis
Employees
—
Headquarters
Berkeley Heights, New Jersey
Founded
1996
Market Cap
57.77M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
137.59K
High Today
$6.85
Low Today
$6.25
Open Price
$6.25
Volume
61.80K
52 Week High
$11.42
52 Week Low
$3.12

CYCC Earnings

-$2.90
-$1.93
-$0.97
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 11, After Hours

You May Also Like

SAF
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure